Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Parmodulin 2 (ML 161) is the inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50: 0.26 μM for the inhibition of platelet P-selectin expression on human platelets). It also inhibits thrombin-induced platelet activation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 30.00 | |
2 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 61.00 | |
10 mg | In stock | $ 85.00 | |
25 mg | In stock | $ 158.00 | |
50 mg | In stock | $ 271.00 | |
100 mg | In stock | $ 490.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 59.00 |
Description | Parmodulin 2 (ML 161) is the inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50: 0.26 μM for the inhibition of platelet P-selectin expression on human platelets). It also inhibits thrombin-induced platelet activation. |
Targets&IC50 | PAR1:0.26 μM |
In vivo | Through P-selectin expression assays, ML-161 has been found to inhibit thrombin-induced platelet activation in a dose-dependent manner. ML-161 selectively inhibits platelet aggregation induced by SFLLRN and thrombin through PAR1 (proteinase-activated receptor 1), without affecting platelet aggregation triggered by AYPGKF, thromboxane, or ADP (adenosine diphosphate). |
Synonyms | ML 161 |
Molecular Weight | 361.23 |
Formula | C17H17BrN2O2 |
CAS No. | 423735-93-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 36.1 mg/mL (100 mM)
Ethanol: 36.1 mg/mL (100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Parmodulin 2 423735-93-7 GPCR/G Protein Protease-activated Receptor aggregation receptor SFLLRN-induced PAR1 Protease Activated Receptor (PAR) Thrombin receptors inhibit platelet ML-161 ML 161 protease-activated P-selectin Parmodulin-2 thrombus Parmodulin2 formation Inhibitor ML161 inhibitor